Meningitis vaccine could protect against gonorrhoea, studies find
BMJ 2022; 377 doi: https://doi.org/10.1136/bmj.o997 (Published 19 April 2022) Cite this as: BMJ 2022;377:o997- Elisabeth Mahase
- The BMJ
The meningitis vaccine could be used to provide some protection against gonorrhoea, researchers have said.
In a collection of studies published in Lancet Infectious Diseases they reported that two doses of the 4CMenB vaccine were around 33% to 40% effective against gonorrhoea in adolescents and young adults. A separate modelling study indicated that vaccinating the people most at risk could prevent 110 000 gonorrhoea cases in England and save the NHS £8m (€9.7m; $10.4m) over 10 years.
No vaccine for gonorrhoea currently exists, and growing resistance to antibiotics has led to treatments becoming less effective. More than 80 million new cases of gonorrhoea were recorded worldwide …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £164 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£30 / $37 / €33 (excludes VAT)
You can download a PDF version for your personal record.